SCHEMBL28665690

SCHEMBL28665690

COC1(C#CC2=CCCCC2)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.39
TSHR P16473 2/20 0.36
ALOX15 P16050 1/20 0.36
ATM Q13315 1/20 0.36
GPR183 P32249 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 1/20 0.34
MMP13 P45452 2/20 0.34
ADAM17 P78536 2/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28649296 0.86 GRM5 (0.40) GRM5TSHRALOX15ATMMEN1
SCHEMBL28654152 0.77 GPR119 (0.45) GRM5TSHRALOX15ATMGPR183
SCHEMBL25238516 0.76 CYP1A2 (0.36) GRM5ATMALDH1A1MAPT
SCHEMBL28653404 0.75 USP2 (0.45) TSHRALOX15ATMUSP2SMN1; SMN2
SCHEMBL28643218 0.75 GPR119 (0.41) GPR183GPR119HPGD
SCHEMBL30437960 0.75 GRM5 (0.54) GRM5GPR183
SCHEMBL31556485 0.73 MAPT (0.48) GPR183MAPTMMP13GPR119
SCHEMBL25799625 0.73 GRM5 (0.53) GRM5
SCHEMBL28670704 0.72 USP2 (0.43) USP2SMN1; SMN2MMP13ADAM17GPR119
SCHEMBL28646247 0.72 GRM5 (0.57) GRM5TSHRALOX15ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113620945-B RET inhibitor, pharmaceutical composition thereof and application of RET inhibitor in medicines 广东东阳光药业股份有限公司 2024-08-23 CN disclosed
CN-113620945-A RET inhibitor, pharmaceutical composition thereof and application thereof in medicines 广东东阳光药业有限公司 2021-11-09 CN disclosed